Teva cancels collaboration with Proteologics, Globes reports Teva (TEVA) has decided to terminate the licensing agreement with Proteologics to develop several molecules, Globes reports. The termination is part of Teva's new strategic plan. Reference Link
News For TEVA From The Last 14 Days
Check below for free stories on TEVA the last two weeks.